Related Experiment Videos
Verapamil: an effective calcium blocking agent for pediatric patients
Pediatrics
|May 1, 1983
Summary
Verapamil, a calcium channel blocker, effectively treats cardiac dysrhythmias like supraventricular tachycardia and atrial flutter in all ages. Pediatricians should understand its pediatric uses and potential hazards.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Verapamil is a recently FDA-approved slow-channel calcium-blocking agent.
- It is indicated for cardiac dysrhythmias across all age groups.
Purpose of the Study:
- To inform pediatricians about verapamil's use in children.
- To detail verapamil's indications, contraindications, adverse reactions, administration, and overdose treatment.
Main Methods:
- Review of verapamil's pharmacological actions.
- Analysis of clinical investigations and potential therapeutic uses.
Main Results:
- Verapamil slows atrioventricular node conduction, treating supraventricular tachycardia and atrial flutter.
- It may relieve left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy.
Conclusions:
- Verapamil is a valuable therapeutic option for various cardiac conditions.
- Awareness of its pediatric applications and safety profile is crucial for healthcare providers.